A d v e r t i s e m e n t

A d v e r t i s e m e n t

PROFESSIONAL     SWITCH TO PUBLIC
JOIN     LOGIN            

Tony Abboud MBT

MEMBER SINCE: Nov 16, 2006
LAST UPDATED: Apr 23, 2007

PROFILE: SemBioSys is developing insulin to serve the expanding diabetes market and to facilitate the commercialization of alternative insulin delivery technologies. Until recently, insulin could only be administered through injection; however, with the recent approval of Pfizer's inhaled insulin (Exhubra®) and progress in other delivery technologies, insulin will soon be increasingly administered through non-injected means.

Members: login to view contact information.
Inst./Company Sembiosys Genetics
Dept. Business Development
Position Business Analyst
Province AB
Country Canada
Category Industry
Member Id# 1429

Tony Abboud


Search Links for "Tony Abboud Calgary": Google
note: the search results are based on passing the member's name (city) to the specified search engines. The accuracy of the results cannot be guaranteed.

Keywords: